Cost and Financial Challenges of Accessing Bone Marrow Transplantation: Opinion Survey in a Nigerian Tertiary Institution
Article Sidebar
Main Article Content
Abstract
Background: Bone Marrow Transplantation is a procedure that involves infusion of bone marrow cells to a recipient to treat bone marrow diseases like leukemia, sickle cell disease and autoimmune diseases. This medical intervention was first done in the early sixties and has since become popular in many countries. However, same cannot be said of African countries especially resource poor nations like Nigeria due to the expensive nature of the procedure. This study is aimed at seeking the opinion of Nigerians in a university community concerning the cost of Bone Marrow Transplantation and how to subsidize the cost and make the treatment accessible for Nigerians.
Materials and Methods: A questionnaire was used to collect information from participants at Edo University Iyamho, Edo State, Nigeria. Data was analyzed using SPSS version 23.
Results: A total of 196 respondents were interviewed out of which 85.2% said the Bone Marrow Transplantation is very expensive and same percentage of respondents said government’s intervention would reduce the cost. One hundred and sixty-five (84.2%) agreed that the role of National Health Insurance Scheme will also reduce the cost. Corruption was identified by 86.3% of participants as the major impediment towards subsidizing the cost of the procedure.
Conclusion/Recommendation: We conclude that the cost of Bone Marrow Transplantation is very expensive to Nigerians and government need to play vital role towards subsidizing the cost. Activating the National Health Insurance Scheme and tackling corruption are the main ways the cost would be subsidized.
Article Details
References
Alexander T, Arnold R, Hiepe F, Radbruch A. Resetting the immune system with immunoablation and autologous haematopoietic stem cell transplantation in autoimmune diseases. Clinical and Experimental Rheumatology. 2016;34:53–57.
Available:https://www.maxhealthcare.in
/top-procedures/bone-marrow-transplant-
bmt (Assessed 23rd May, 2020).
Kasakura S. Great contributions of E. Donnall Thomas to the development of clinical applications of bone marrow transplantation, leading to the 1990 Nobel Prize in Medicine/Physiology. Int J Hematol. 2005;81(2):87-88.
Bone marrow foundation, cancer research pioneer dies. Archived from the original on 6th; 2013.
Bazuaye N, Nwogoh B, Ikponmwen D, Irowa O, Okugbo S, et al. First successful allogeneic hematopoietic stem cell transplantation for a sickle cell disease patient in a low resource country (Nigeria): a case report. Ann Transplant. 2014;19: 210-213.
Available:https://newscorner.com.ng (accessed 1st April 2020)
Smith TJ, Hillner BE, Desch CE. Efficacy and cost effectiveness of cancer treatment rational allocation of resorces based on decision analysis. J Natl Cancer Inst. 1993;85:1460-1474.
Welch HG, Larson EB. Cost effectiveness or bone marrow transplantation in acute nonlymphocytic leukemia. N Engl J Med. 1989;321:807-812.
Alexander T, Arnold R, Hiepe F, Radbruch A (1 July 2016). Resetting the immune system with immunoablation and autologous haematopoietic stem cell transplantation in autoimmune diseases. Clinical and Experimental Rheumatology. 2016;34:53–57.
Frederick M, Weeks MD. The true cost of Bone marrow transplantation. The American Journal of the Medical Sciences. 1997;314:101-112.
Available:https://doi.org/10.1016/s0002- (15) 40176-
Edewor PA, Aluko YA, Folarin SF. Managing Ethnic and Cultural Diversity for National Integration in Nigeria. Developing Country Studies. 2014;4(6):2224-2225.
Rasak B, Rasaq O. Indigenous capitalist class, social stratification and life chances in the contemporary Nigeria Society. Public Policy and Administration Research 2014;4(7):11-16.
Robertson C, Ndebele N, Mhango Y. A survey of the Nigerian middle class. fastestbillion; 2011.
(Assessed 23rd May 2020)
Akinyanju OO: A profile of sickle cell disease in Nigeria. Ann NY Acad Sci, 1989;565:126–136.
Mustapha OJ, Abubakar FH: Study of the prevalence of sickle cell disease in Kano metropolis and its suburbs in Northern Nigeria. J Basic Applied Sci. 2001;10:219–225.
Nwogoh B, Adewowin A, Iheanacho OE, Bazuaye GN: Prevalence of haemo-globin variants in Benin City. Ann Biomed Sci. 2012;11(2):60–64.
Kassim AA, Sharma D. Hematopoietic stem cell transplantation for sickle cell disease: The changing landscape. Hematology/Oncology and Stem Cell Therapy. 2017;10(4)259-266.
Oshrine B, Talano J. Curative treatment for severe sickle cell disease: Allogeneic Transplantation. Clinical Advances in Hematology & Oncology. 2015;13(4):249-256.
Saito AM, Cutler C, Zahrieh D et al. Cost of allogeneic hematopoietic cell transplantation with high-dose regimens. Biol Blood Marrow Transplant. 2008; 14:197-207.
Lee SJ, Klar N, Weeks JC, et al. Predicting costs of stem cell transplantation. J Clin Oncol. 2000;18:64-71.
Westerman I, Waters T, Benett C. Health care economics and bone marrow transplantation. Blood Stem Cell Transplantation. 1997;377-399.
Sunday A. Adebisi, Joyce M. Odiachi, Ngozi A. Chikere. The National Health Insurance Scheme(NHIS) in Nigeria: Has the policy achieved its intended objectives? Acad J Eco Stud. 2019;5:97-104.
Odeyemi, I.A. Community-based health insurance programmes and the national health insurance scheme of Nigeria: Challenges to uptake and integration. Int J Equity Health. 2014;13:20.
Available:https://doi.org/10.1186/1475-9276-13-20
Christina CP, Latifat TT, Collins NF, Olatunbosun AT. National health insurance scheme: How receptive are the private healthcare practitioners in a local government area of Lagos state. Niger Med J. 2014;55(6):512–516.
DOI:10.4103/0300-1652.144712
Abiola AO, Ladi-Akinyemi TW, Oyeleye OA, Oyeleke GK, Olowoselu OI, Abdulkareem AT. Knowledge and utilisation of National Health Insurance Scheme among adult patients attending a tertiary health facility in Lagos State, South-Western Nigeria. Afr J Prm Health Care Fam Med. 2019;11(1):a2018.
Available:https://doi.org/10.4102/phcfm.vllil.2018
Adewole DA , Dairo MD, Bolarinwa OA . Awareness and coverage of the National Health Insurance Scheme among Formal Sector Workers in Ilorin, Nigeria. Afr. J. Biomed Res. 2016;19(1):1-10.
Taryn Vian. Review of corruption in the health sector: Theory, methods and interventions. Health policy and planning. 2008;23:83-94.
Onwujekwe O, Agwu P, Orjiakor C, McKee Martin, Hutchinson E, et al. Corruption in Anglophone west Africa health systems: A systemic review of its different varianyts and the factors that sustain them. Health policy and planning. 2019;34:529-543.
Mostert S, Njuguma F, Olbara G, et al. Corruption in health-care systems and its effect on cancer care in Africa. Lancet Oncol. 2015;16:e394-e404.
DOI:10.1016/s1470-2045(15)00163-1
Tormusa DO, Idom AM. The impediments of corruption on the efficiency of healthcare service delivery in Nigeria. Online Journal of Health Ethics. 2016;12: 1-3.